| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72603-328-01 | 72603-328 | HUMAN PRESCRIPTION DRUG | LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | CAPSULE | ORAL | 20241201 | N/A | ANDA | ANDA218122 | NorthStar Rx LLC | LOPERAMIDE HYDROCHLORIDE | 2 mg/1 | 100 CAPSULE in 1 BOTTLE (72603-328-01) |
| 72603-328-02 | 72603-328 | HUMAN PRESCRIPTION DRUG | LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | CAPSULE | ORAL | 20241201 | N/A | ANDA | ANDA218122 | NorthStar Rx LLC | LOPERAMIDE HYDROCHLORIDE | 2 mg/1 | 500 CAPSULE in 1 BOTTLE (72603-328-02) |
| 70518-4283-1 | 70518-4283 | HUMAN PRESCRIPTION DRUG | LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | CAPSULE | ORAL | 20250214 | N/A | ANDA | ANDA218122 | REMEDYREPACK INC. | LOPERAMIDE HYDROCHLORIDE | 2 mg/1 | 30 CAPSULE in 1 BLISTER PACK (70518-4283-1) |
| 70518-4283-2 | 70518-4283 | HUMAN PRESCRIPTION DRUG | LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | CAPSULE | ORAL | 20250401 | N/A | ANDA | ANDA218122 | REMEDYREPACK INC. | LOPERAMIDE HYDROCHLORIDE | 2 mg/1 | 15 CAPSULE in 1 BLISTER PACK (70518-4283-2) |
| 70518-4283-3 | 70518-4283 | HUMAN PRESCRIPTION DRUG | LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | CAPSULE | ORAL | 20250407 | N/A | ANDA | ANDA218122 | REMEDYREPACK INC. | LOPERAMIDE HYDROCHLORIDE | 2 mg/1 | 10 CAPSULE in 1 BLISTER PACK (70518-4283-3) |